HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-14.04%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.72B
AUM Growth
+$2.72B
(-9.8%)
Cap. Flow
+$34.4M
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
53.43%
Holding
50
New
7
Increased
20
Reduced
7
Closed
12
Top Buys
| 1 |
Danaher
DHR
|
$127M |
| 2 |
DexCom
DXCM
|
$119M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$109M |
| 4 |
Intuitive Surgical
ISRG
|
$99.4M |
| 5 |
IQVIA
IQV
|
$89.5M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$195M |
| 2 |
Merck
MRK
|
$136M |
| 3 |
HCA Healthcare
HCA
|
$118M |
| 4 |
AGN
Allergan plc
AGN
|
$117M |
| 5 |
Labcorp
LH
|
$106M |
Sector Composition
| 1 | Healthcare | 88.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Intuitive Surgical
ISRG
$170B
| $186M | 5.81% | 387,920 +207,460 | +115% | +$99.4M |
|
|
2
DexCom
DXCM
$29.5B
| $176M | 5.5% | 1,468,752 +994,072 | +209% | +$119M |
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $165M | 5.15% | 440,968 +40,968 | +10% | +$15.3M |
|
|
4
Danaher
DHR
$147B
| $155M | 4.85% | 1,503,750 +1,227,550 | +444% | +$127M |
|
5
CVS Health
CVS
$92.8B
| $153M | 4.77% | 2,328,560 +1,048,800 | +82% | +$68.7M |
|
6
LivaNova
LIVN
$3.08B
| $139M | 4.34% | 1,517,780 +822,670 | +118% | +$75.2M |
|
7
Medtronic
MDT
$119B
| $134M | 4.19% | 1,472,790 -217,060 | -13% | -$19.7M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $125M | 3.9% | 1,947,640 +1,011,472 | +108% | +$64.8M |
|
9
Cigna
CI
$80.3B
| $111M | 3.47% | 584,390 -15,610 | -3% | -$2.96M |
|
10
Haemonetics
HAE
$2.63B
| $110M | 3.44% | 1,100,140 +800,901 | +268% | +$80.1M |
|
|
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
| $109M | 3.41% | +462,370 | New | +$109M |
|
12
Pacira BioSciences
PCRX
$1.2B
| $107M | 3.36% | 2,498,128 +552,588 | +28% | +$23.8M |
|
13
Stryker
SYK
$150B
| $93.1M | 2.91% | 593,623 -281,377 | -32% | -$44.1M |
|
|
14
IQVIA
IQV
$32.4B
| $89.5M | 2.8% | +770,550 | New | +$89.5M |
|
15
UnitedHealth
UNH
$281B
| $84M | 2.63% | 337,280 -11,240 | -3% | -$2.8M |
|
16
Madrigal Pharmaceuticals
MDGL
$9.76B
| $77.7M | 2.43% | 688,890 +426,030 | +162% | +$48M |
|
|
XENT
17
DELISTED
Intersect ENT, Inc
XENT
| $70.2M | 2.19% | 2,490,110 +540,110 | +28% | +$15.2M |
|
18
Encompass Health
EHC
$12.3B
| $68.2M | 2.13% | +1,105,920 | New | +$68.2M |
|
19
Boston Scientific
BSX
$156B
| $63.4M | 1.98% | 1,794,610 +391,660 | +28% | +$13.8M |
|
|
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
| $61.4M | 1.92% | 3,723,949 +139,369 | +4% | +$2.3M |
|
|
MDCO
21
DELISTED
Medicines Co
MDCO
| $55M | 1.72% | 2,871,283 +2,189,083 | +321% | +$41.9M |
|
22
Neurocrine Biosciences
NBIX
$13.8B
| $54.9M | 1.72% | 768,630 +358,274 | +87% | +$25.6M |
|
|
23
Merck
MRK
$210B
| $47.7M | 1.49% | 624,080 -1,784,800 | -74% | -$136M |
|
24
Dynavax Technologies
DVAX
$1.19B
| $42.2M | 1.32% | 4,613,280 +1,491,811 | +48% | +$13.7M |
|
|
AMRN
25
Amarin Corp
AMRN
$311M
| $41.5M | 1.3% | +3,046,083 | New | +$41.5M |
|